Renaissance Technologies’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $293K | Sell |
92,100
-12,400
| -12% | -$48.6K | ﹤0.01% | 2797 |
|
|
2025
Q4 | $449K | Buy |
104,500
+74,325
| +246% | +$666K | ﹤0.01% | 2617 |
|
|
2025
Q3 | $1.18M | Sell |
30,175
-1,059
| -3% | -$30.2K | ﹤0.01% | 2404 |
|
|
2025
Q2 | $729K | Buy |
31,234
+1,724
| +6% | +$40.8K | ﹤0.01% | 2657 |
|
|
2025
Q1 | $449K | Sell |
29,510
-1,833
| -6% | -$27.7K | ﹤0.01% | 2786 |
|
|
2024
Q4 | $575K | Buy |
31,343
+539
| +2% | +$5.87K | ﹤0.01% | 2780 |
|
|
2024
Q3 | $342K | Buy |
30,804
+1,200
| +4% | +$14.1K | ﹤0.01% | 2934 |
|
|
2024
Q2 | $275K | Sell |
29,604
-7,409
| -20% | -$177K | ﹤0.01% | 2940 |
|
|
2024
Q1 | $1.21M | Buy |
37,013
+17,651
| +91% | +$458K | ﹤0.01% | 2365 |
|
|
2023
Q4 | $518K | Buy |
19,362
+10,698
| +123% | +$443K | ﹤0.01% | 2752 |
|
|
2023
Q3 | $524K | Sell |
8,664
-3,393
| -28% | -$318K | ﹤0.01% | 2688 |
|
|
2023
Q2 | $1.23M | Buy |
12,057
+11,069
| +1,120% | +$1.52M | ﹤0.01% | 2339 |
|
|
2023
Q1 | $175K | Buy |
+988
| New | +$331K | ﹤0.01% | 3332 |
|
|
2022
Q2 | – | Sell |
-4,421
| Closed | -$1.93M | – | 4638 |
|
|
2022
Q1 | $1.93M | Sell |
4,421
-5,605
| -56% | -$2.3M | ﹤0.01% | 2256 |
|
|
2021
Q4 | $4.4M | Buy |
+10,026
| New | +$5.04M | 0.01% | 1620 |
|
|
2021
Q3 | – | Sell |
-4,346
| Closed | -$2.23M | – | 3925 |
|
|
2021
Q2 | $2.23M | Sell |
4,346
-2,917
| -40% | -$1.85M | ﹤0.01% | 2186 |
|
|
2021
Q1 | $5.68M | Sell |
7,263
-479
| -6% | -$328K | 0.01% | 1571 |
|
|
2020
Q4 | $4.22M | Sell |
7,742
-563
| -7% | -$295K | ﹤0.01% | 1700 |
|
|
2020
Q3 | $3.8M | Buy |
8,305
+5,837
| +237% | +$3.39M | ﹤0.01% | 1737 |
|
|
2020
Q2 | $1.52M | Buy |
+2,468
| New | +$1.36M | ﹤0.01% | 2333 |
|
|
2019
Q1 | – | Sell |
-11,476
| Closed | -$5.37M | – | 3750 |
|
|
2018
Q4 | $5.37M | Buy |
+11,476
| New | +$7.4M | 0.01% | 1684 |
|
|
2016
Q4 | – | Sell |
-6,886
| Closed | -$2.07M | – | 3500 |
|
|
2016
Q3 | $2.07M | Buy |
+6,886
| New | +$1.49M | ﹤0.01% | 2164 |
|
|
2016
Q2 | – | Sell |
-2,483
| Closed | -$556K | – | 3542 |
|
|
2016
Q1 | $556K | Buy |
2,483
+1,162
| +88% | +$347K | ﹤0.01% | 2819 |
|
|
2015
Q4 | $802K | Sell |
1,321
-5,668
| -81% | -$3.11M | ﹤0.01% | 2562 |
|
|
2015
Q3 | $3.6M | Buy |
6,989
+1,187
| +20% | +$795K | 0.01% | 1612 |
|
|
2015
Q2 | $2.54M | Sell |
5,802
-1,776
| -23% | -$686K | 0.01% | 1910 |
|
|
2015
Q1 | $2.74M | Buy |
7,578
+6,914
| +1,041% | +$2.62M | 0.01% | 1743 |
|
|
2014
Q4 | $238K | Buy |
+664
| New | +$214K | ﹤0.01% | 2645 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
Renaissance Technologies's TVRD Position: Q1 2026 in Review
Renaissance Technologies reduced its Tvardi Therapeutics (TVRD) stake by 12% in Q1 2026, selling an estimated $48.6K and leaving 92,100 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #2797.
Renaissance Technologies first reported a position in TVRD in Q4 2014 and has held it in 28 quarters since. The position peaked at $5.68M in Q1 2021. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- Renaissance Technologies held 92,100 shares of Tvardi Therapeutics worth $293K as of Q1 2026.
- Renaissance Technologies sold 12,400 Tvardi Therapeutics shares in Q1 2026, an estimated $48.6K.
- Tvardi Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q1 2026, its #2797 holding.
- Renaissance Technologies first reported a position in Tvardi Therapeutics in Q4 2014 and has held it in 28 quarters since.
- Renaissance Technologies's Tvardi Therapeutics position peaked at $5.68M in Q1 2021.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.